These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12695372)

  • 1. A national drug agency.
    West R; Borden EK; Collet JP; Rawson NS; Tonks RS
    CMAJ; 2003 Apr; 168(8):962-3. PubMed ID: 12695372
    [No Abstract]   [Full Text] [Related]  

  • 2. We need Romanow's National Drug Agency.
    CMAJ; 2003 Feb; 168(3):249, 251. PubMed ID: 12566321
    [No Abstract]   [Full Text] [Related]  

  • 3. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Social law contradicts economic regulation. Home care patient dead--tablets in the trash].
    Thöns M
    MMW Fortschr Med; 2005 Sep; 147(39):18. PubMed ID: 16245775
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to "The common drug review: a NICE start for Canada?".
    Lee KM; la Fleur DP
    Health Policy; 2007 Jan; 80(1):1. PubMed ID: 16597473
    [No Abstract]   [Full Text] [Related]  

  • 6. An analysis of China's national essential medicines policy.
    Guan X; Liang H; Xue Y; Shi L
    J Public Health Policy; 2011 Aug; 32(3):305-19. PubMed ID: 21614030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential stifling effects of pharmaco-economics and regulatory policies.
    Data JL
    Am J Cardiol; 1998 Apr; 81(8A):34F-35F. PubMed ID: 9604904
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug policy: the challenge is to overcome fragmentation.
    McFarlance A
    Healthc Pap; 2002; 3(1):38-42: discussion 87-94. PubMed ID: 12811109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to medicines and global health: will Canada lead or flounder?
    Orbinski J
    CMAJ; 2004 Jan; 170(2):224-6. PubMed ID: 14734437
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals: drug importation--2005. End of Year Issue Brief.
    Varma P; Seay M
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug policy: an oxymoron?
    Gray J
    Healthc Pap; 2002; 3(1):56-62; discussion 87-94. PubMed ID: 12811112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Common Drug Review: a NICE start for Canada?
    McMahon M; Morgan S; Mitton C
    Health Policy; 2006 Aug; 77(3):339-51. PubMed ID: 16214257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing pharmacoeconomic guidelines in Latin America: lessons learned.
    Augustovski F; Melendez G; Lemgruber A; Drummond M
    Value Health; 2011; 14(5 Suppl 1):S3-7. PubMed ID: 21839895
    [No Abstract]   [Full Text] [Related]  

  • 15. An Italian perspective: studying the cost-effectiveness of sofosbuvir before completion of national price negotiations.
    Messori A; Maratea D; Fadda V; Gatto R; Trippoli S
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):813-4. PubMed ID: 24901827
    [No Abstract]   [Full Text] [Related]  

  • 16. India's generics-only drug policy could put health at risk.
    Gourd E
    Lancet Oncol; 2017 Jul; 18(7):e373. PubMed ID: 28583793
    [No Abstract]   [Full Text] [Related]  

  • 17. [Regulation for improving economics in drug treatment].
    Holstein L; Koch B
    Chirurg; 2006 Jul; Suppl():214-6. PubMed ID: 17855869
    [No Abstract]   [Full Text] [Related]  

  • 18. Moving from opacity to transparency in pharmaceutical policy.
    Dhalla I; Laupacis A
    CMAJ; 2008 Feb; 178(4):428-31. PubMed ID: 18268270
    [No Abstract]   [Full Text] [Related]  

  • 19. The Canadians are killing us.
    Struble RA
    Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58-9. PubMed ID: 12592981
    [No Abstract]   [Full Text] [Related]  

  • 20. Action programme on essential drugs.
    WHO Chron; 1979 Jun; 33(6):203-8. PubMed ID: 462952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.